# SECTION 5 - 510(k) Summary

# Introduction

According to the requirements of 21 CFR 807.92, the following information provides sufficient detail to understand the basis for a determination of substantial equivalence.

The assigned 510(k) number is: K 110830_

# Submitter Address Phone number Fax number

SEPPIM S.A.S.   
Zone Industrielle, 61500 SEES, FRANCE + 33 (0)2 33 81 21 00   
+ 33 (0)2 33 28 77 51

# Contact

Valérie GOURDON (Email: v.gourdon@elitechgroup.com)

Date of Preparation

March 24th, 2011

# Device names

# REAGENT

Trade/proprietary Name:

Common or Usual Name:   
Device Class   
Classification name   
Product code

Class II Calcium test system (Sec.862. 1145) CJY- Azo Dye, Calcium

# Predicate device

Stanbio Calcium LiquiColor® (Arsenazo I1) (K921625)

# Device description

The device for this submission is available as kit only. It consists of 1 reagent "R". Reagent R contains: MES buffer $( p \mathsf { H } \ \mathsf { \pm } \ \mathsf { G } . 5 0 )$ , Arsenazo III [2,7-(bis(2- arsonophenylazo))-1,8-dihydronaphtalene-3,6-disulphonic acid].

# Intended Use

# Comparison to Predicate device

<table><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">ELITech Clinical Systems DeviceCALCIUM ARSENAZO)</td><td colspan="1" rowspan="1">Predicate deviceStanbio Calcim LiquiColo(Arsenazo III) K921625)</td></tr><tr><td colspan="1" rowspan="1">Intended use</td><td colspan="1" rowspan="1">Intended for the quantitative in vitrodiagnostic determination of total cal-cium in human serum and plasma onELITech Clinical Systems Selectraanalyzers.It is not intended for use in Point ofCare settings.</td><td colspan="1" rowspan="1">For the quantitative colorimetric de-termination of calcium in human serumand plasma on Stanbio LaboratorySirrus Chemistry Analyzer.</td></tr><tr><td colspan="1" rowspan="1">Indication for Use</td><td colspan="1" rowspan="1">Calcium measurements are used inthe diagnosis and treatment of para-thyroid disease, a variety of bonediseases, chronic renal disease andtetany (intermittent muscular contrac-tions or spasms).</td><td colspan="1" rowspan="1">Calcium measurements are used inthe diagnosis and treatment of para-thyroid disease, a variety of bone dis-eases, chronic renal disease and teta-ny (intermittent muscular contractionsor spasms).</td></tr><tr><td colspan="1" rowspan="1">Assay protocol</td><td colspan="1" rowspan="1">Colorimetric test           i</td><td colspan="1" rowspan="1">Colorimetric test</td></tr><tr><td colspan="1" rowspan="1">Composition</td><td colspan="1" rowspan="1">Reagent R:MES buffer (pH 6.50) 100 mmol/L;Arsenazo III           200 μmoVL;</td><td colspan="1" rowspan="1">Reagent :Buffer;Arsenazo III &gt; 0.15 mmol/L;8-Hydroxyquinoline sulfonate 5.0 mM;Surfactant</td></tr><tr><td colspan="1" rowspan="1">Appearance of re-agents</td><td colspan="1" rowspan="1">Liquid form, ready to use</td><td colspan="1" rowspan="1">Liquid form, ready to use</td></tr><tr><td colspan="1" rowspan="1">Sample type</td><td colspan="1" rowspan="1">SerumPlasma</td><td colspan="1" rowspan="1">SerumPlasma</td></tr><tr><td colspan="1" rowspan="1">Reagent storage</td><td colspan="1" rowspan="1">Store at 2-8 °C and protect from light.The reagent is stable until the expirydate stated on the label.</td><td colspan="1" rowspan="1">Store at 2-30 C the reagent is stableuntil the expiry date stated on the la-bel.</td></tr><tr><td colspan="1" rowspan="1">Expected values</td><td colspan="1" rowspan="1">Serum/plasma:8.6 - 10.3 mg/dL</td><td colspan="1" rowspan="1">Serum/plasma:8.5 - 10.4 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Instrument</td><td colspan="1" rowspan="1">Selectra ProM Analyzer</td><td colspan="1" rowspan="1">Sirrus Chemistry Analyzer</td></tr><tr><td colspan="1" rowspan="1">Measuring range</td><td colspan="1" rowspan="1">5.0 - 15.0 mg/dL</td><td colspan="1" rowspan="1">0 to 15 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Limit of detection(LoD)</td><td colspan="1" rowspan="1">0.36 mg/dL</td><td colspan="1" rowspan="2"></td></tr><tr><td colspan="1" rowspan="1">Limit of quantification(LOQ</td><td colspan="1" rowspan="1">5.00 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Precision</td><td colspan="1" rowspan="1">Within runLevel 8.75 mg/dL     CV= 1.3%Level 9.68 mg/dL     CV= 0.9%Level 11.97 mg/dL   CV= 0.7%TotalLevel 8.75 mg/dL     CV= 1.9%Level 9.68 mg/dL    CV= 1.9%Level 11.97 mg/dL    CV= 1.9%</td><td colspan="1" rowspan="1">Within runLevel 11.0 mg/dL CV=1.3%Level 14.3 mg/dL CV=0.9%Run to runLevel 11.2 mg/dL CV=1.1%Level 14.3. mg/dL CV=1.3%</td></tr><tr><td colspan="1" rowspan="1">Method comparison</td><td colspan="1" rowspan="1">y= 1.008 x - 0 mg/dLr= 0.996range: 4.90 to 14.37 mg/dL</td><td colspan="1" rowspan="1">y= 0.99 x + 0.10 mg/dLr= 0.989range: 4.7 to 15.9 mg/dL</td></tr><tr><td colspan="1" rowspan="1">Limitations</td><td colspan="1" rowspan="1">Hemoglobin: No significant interfer-ence up to 500 mg/dL</td><td colspan="1" rowspan="1">Bilirubin: No interference up to 20mg/dL</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">ELITech Clinical Systems Device(CALCIUM ARSENAZO)</td><td colspan="1" rowspan="1">Predicate device(Stanbio Calcium LiquiColor®(Arsenazo III) K921625)</td></tr><tr><td colspan="1" rowspan="1">b</td><td colspan="1" rowspan="1">Triglycerides: No significant interfer-ence up to 1119 mg/dL. A positivebias is observed with triglyceridesconcentratsion above 1119 mg/dL.Unconjuqated bilirubin: No signifi-cant interference up to 30.0 mg/dL(513 µmol/L).Conjugated bilirubin: No significantinterference up to 29.5 mg/dL (504μmol/L).Magnesium: No significant interfer-ence up to 10.91 mg/dL.Ascorbic acid: No significant interfer-ence up to 20 mg/dL.Acetaminophen: No significant inter-ference up to 30 mg/dL.Acetylsalicylic acid: No significantinterference up to 200 mg/dL.</td><td colspan="1" rowspan="1">Hemoglobin: No interference up to500 mg/dlLipemia: May cause elevated results.</td></tr><tr><td colspan="1" rowspan="1">Calibration Frequency</td><td colspan="1" rowspan="1">28 days</td><td colspan="1" rowspan="1">30 days</td></tr><tr><td colspan="1" rowspan="1">On board stability</td><td colspan="1" rowspan="1">refrigerated area : 28 days</td><td colspan="1" rowspan="1">30 days</td></tr><tr><td colspan="1" rowspan="1">Calibrator</td><td colspan="1" rowspan="1">Recommended calibration material(not included):ELITech Clinical Systems ELICAL 2</td><td colspan="1" rowspan="1">Recommended calibration material(not included):Ser-T-Cal® MultiCalibrator</td></tr><tr><td colspan="1" rowspan="1">Controls</td><td colspan="1" rowspan="1">Recommended quality control material(not included):ELITech Clinical Systems ELITROL I(Normal control)ELITech Clinical Systems ELITROL 1I(Pathologic control)</td><td colspan="1" rowspan="1">Recommended quality control material(not included):Ser-T-Fy 1 (Normal control)Ser-T-Fy II (Abnormal control)</td></tr></table>

<table><tr><td colspan="2">Device names REAGENT</td></tr><tr><td>Trade/proprietary Name: Common or Usual Name:</td><td>ELITech Clinical Systems ALBUMIN Albumin, &quot;ALBUMIN&quot;</td></tr><tr><td>Device Class</td><td>Class II</td></tr><tr><td>Classification name</td><td>Albumin test system (Sec.862. 1035)</td></tr><tr><td>Product code</td><td>CIX - Bromcresol green dye-binding, Albumin</td></tr><tr><td>Predicate device</td><td>Roche Diagnostics Albumin Gen.2 (K063744)</td></tr><tr><td></td><td>The device for this submission is available as kit only. It consists of 1</td></tr><tr><td>Device description</td><td>reagent &quot;R&quot;. Reagent R contains: Succinate buffer (pH 4.20), Bromocresol green, Brij 35.</td></tr><tr><td>Intended Use</td><td>ELITech Clinical Systems ALBUMIN is intended for the quantitative in vitro diagnostic determination of albumin in human serum and plasma on ELI-</td></tr><tr><td></td><td>Tech Clinical Systems Selectra analyzers. It is not intended for use in Point of Care settings.</td></tr><tr><td>Indication for use</td><td>Albumin measurements are used in the diagnosis and treatment of numer- ous diseases involving primarily the liver or kidneys.</td></tr></table>

# Comparison to Predicate device

Page 5.4 of 5.9 pages   

<table><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">ELITech Clinical Systems Device(ALBUMIN)</td><td colspan="1" rowspan="1">Predicate device(Roche Diagnostics Albumin Gen.2K063744)</td></tr><tr><td colspan="1" rowspan="1">Intended use</td><td colspan="1" rowspan="1">Intended for the quantitative in vitrodiagnostic determination of albumin inhuman serum and plasma on ELITechClinical Systems Selectra analyzers.It is not intended for use in Point ofCare settings.</td><td colspan="1" rowspan="1">For in vitro diagnostic use in the quan-titative determination of albumin inhuman serum and plasma on the co-bas c111 system.</td></tr><tr><td colspan="1" rowspan="1">Indication for Use</td><td colspan="1" rowspan="1">Albumin measurements are used inthe diagnosis and treatment of numer-ous diseases involving primarily theliver or kidneys.</td><td colspan="1" rowspan="1">Albumin measurements are used inthe diagnosis and treatment of numer-ous diseases involving primarily theliver or kidneys.</td></tr><tr><td colspan="1" rowspan="1">Assay protocol</td><td colspan="1" rowspan="1">Colorimetric test</td><td colspan="1" rowspan="1">Colorimetric test</td></tr><tr><td colspan="1" rowspan="1">Composition</td><td colspan="1" rowspan="1">Reagent R:Succinate buffer (pH 4.20) 87 mmoVL;Bromocresol green         0.2 mmoVL;Briij 35                        7.35 mL/L;</td><td colspan="1" rowspan="1">Reagent R1:Citrate (pH 4.1)              95 mmoVL;PreservativeReagent R2:Citrate (pH 4.1)              95 mmoVL ;Bromocresol green         0.66 mmol/L;Preservative</td></tr><tr><td colspan="1" rowspan="1">Appearance of re-agents</td><td colspan="1" rowspan="1">Liquid form, ready to use</td><td colspan="1" rowspan="1">Liquid form, ready for use</td></tr><tr><td colspan="1" rowspan="1">Sample type</td><td colspan="1" rowspan="1">SerumPlasma</td><td colspan="1" rowspan="1">SerumPlasma</td></tr><tr><td colspan="1" rowspan="1">Reagent storage</td><td colspan="1" rowspan="1">Store at 2-25 °C and protect from light.The reagent is stable until the expirydate stated on the label.</td><td colspan="1" rowspan="1">Stored at 15-25 °C.Reagents are stable until the expirydate stated on the label.</td></tr><tr><td colspan="1" rowspan="1">Expected values</td><td colspan="1" rowspan="1">Serum, plasma:Adults:          3.5-5.2 g/dL60-90 years :   3.2-4.6 g/dL&gt; 90 years:     2.9-4.5 g/dLIn ambulatory patients, values aver-age ~0.3 g/dL higher.</td><td colspan="1" rowspan="1">Serum/plasma:Adults (reference range study) : 3.97-4.94 g/dLAdults (consensus values) : 3.5-5.2g/dLTietz:0-4 days : 2.8-4.4 g/dL4 days-14 years: 3.8-5.4 g/dL14 -18 years: 3.2-4.5 g/dL</td></tr><tr><td colspan="1" rowspan="1">Instrument</td><td colspan="1" rowspan="1">Selectra ProM Analyzer</td><td colspan="1" rowspan="1">Cobas c111</td></tr><tr><td colspan="1" rowspan="1">Measuring range</td><td colspan="1" rowspan="1">1.6 - 6.0 g/dL</td><td colspan="1" rowspan="1">0.2 to 6.0 g/dL.</td></tr><tr><td colspan="1" rowspan="1">Limit of detection(LOD)</td><td colspan="1" rowspan="1">0.003 g/dL</td><td colspan="1" rowspan="2">0.2 g/dL</td></tr><tr><td colspan="1" rowspan="1">Limit of quantification(LOQ</td><td colspan="1" rowspan="1">0.50 g/dL</td></tr><tr><td colspan="1" rowspan="1">Precision</td><td colspan="1" rowspan="1">Within runLevel 2.54 g/dL  CV= 0.9%Level 3.53 g/dL  CV= 0.5%Level 4.98 g/dL CV= 0.8%Total</td><td colspan="1" rowspan="1">Within runLevel 4.67 g/dL  CV=0.52%Level 2.99 g/dL  CV=0.76%Level 3.01 g/dL  CV=0.56%Level 5.48 g/dL  CV=0.61%Run to run</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Level 2.54 g/dL  CV= 2.3%Level 3.53 g/dL  CV= 2.1%Level 4.98 mg/dL CV= 2.1%</td><td colspan="1" rowspan="1">Level 4.62 g/dL  CV=1.87%Level2.97 g/dL  CV=1.45%Level2.98 g/dL  CV=1.83%Level5.40 g/dL  CV=1.24%</td></tr><tr><td colspan="1" rowspan="1">Method comparison</td><td colspan="1" rowspan="1">y= 0.961x + 0.12 g/dLr= 0.997range: 1.43 to 5.89 g/dL.</td><td colspan="1" rowspan="1">y= 1.017 x + 0.0164 g/dLr= 0.9997range: 0.26 to 5.93 g/dL</td></tr><tr><td colspan="1" rowspan="1">Limitations</td><td colspan="1" rowspan="1">Hemoglobin: No significant interfer-ence up to 500 mg/dL.Triglyceride: No significant interfer-ence up to 3000 mg/dL.Unconjugated bilirubin: No signifi-cant interference up to 30.0 mg/dL(513 µmol/L).Conjugated bilirubin: No significantinterference up to 29.5 mg/dL (504μmol/L).Ascorbic acid: No significant interfer-ence up to 20 mg/dL.Acetaminophen: No significant inter-ference up to 30 mg/dL.Acetylsalicylic acid: No significantinterference up to 200 mg/dL.globulin: No significant interferenceup to 1500 mg/dL.</td><td colspan="1" rowspan="1">Hemoglobin: No significant interfer-ence up to an H Index of 420 (ap-proximate 420 mg/dL).Lipemia_ (Intralipid): No significantinfluence up to an L index of 900.There is poor correlation between theL index (corresponds to turbidity) andtriglycerides concentration.Icterus: No significant influence up toIndex of 60 (approximate  conju-gated and unconjugated bilirubin con-centration of 60 mg/dL (1026 µmol/L)).y-globulin: No significant interference.</td></tr><tr><td colspan="1" rowspan="1">Calibration Frequency</td><td colspan="1" rowspan="1">28 days</td><td colspan="1" rowspan="1">Each lot and as required followingquality control procedures.</td></tr><tr><td colspan="1" rowspan="1">On board stability</td><td colspan="1" rowspan="1">refrigerated area : 28 days</td><td colspan="1" rowspan="1">4 weeks</td></tr><tr><td colspan="1" rowspan="1">Calibrator</td><td colspan="1" rowspan="1">Recommended calibration material(not included):ELITech Clinical Systems ELICAL 2</td><td colspan="1" rowspan="1">Recommended calibration material(not included):Roche Calibrator f.a.s.</td></tr><tr><td colspan="1" rowspan="1">Controls</td><td colspan="1" rowspan="1">Recommended quality control material(not included):ELITech Clinical Systems ELITROL I(Normal control)ELITech Clinical Systems ELITROL II(Pathologic control)</td><td colspan="1" rowspan="1">Recommended quality control material(not included):Roche Precinorm URoche Precipath U</td></tr></table>

# Device name

# CALIBRATOR :

Trade/proprietary Name: ELITech Clinical Systems ELICAL 2 Common or Usual Name: Calibrator, multi-analyte mixture, "ELICAL 2" Device Class Class II Classification name Calibrator (21 CFR 862.1150) Product code JIX- Calibrator, multi-analyte mixture

<table><tr><td>Predicate device</td><td>Roche Diagnostics Calibrator for Automated Systems (C.f.a.s) (K033501)</td></tr><tr><td>Device description</td><td>ELITech Clinical Systems ELICAL 2 is a lyophilized calibrator based on human serum containing constituents to ensure optimal calibration. ELICAL 2 is prepared exclusively from the blood of donors tested individually and found to be negative for HbsAg and to antibodies to HCV and HIV ac- cording to FDA-approved methods or methods in compliance with the Euro- pean Directive 98/79/EC, Annex II, List A.</td></tr><tr><td>Intended Use</td><td>ELITech Clinical Systems ELICAL 2 is a multi-parametric calibrator for in vitro diagnostic use in the calibration of quantitative ELITech Clinical Sys- tems methods on ELITech Clinical Systems Selectra Analyzers.</td></tr></table>

# Comparison to Predicate device

<table><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">ELITech Clinical Systems Device(ELICAL 2)</td><td colspan="1" rowspan="1">Predicate device(Roche Calibrator f.a.s. K033501)</td></tr><tr><td colspan="1" rowspan="1">Intended use</td><td colspan="1" rowspan="1">ELITech Clinical Systems ELICAL2 is a multi-parametric calibratorfor in vitro diagnostic use in thecalibration of quantitative ELITechClinical Systems methods onELITech Clinical Systems Selec-tra Analyzers.</td><td colspan="1" rowspan="1">For in vitro diagnostic use in thecalibration of quantitative Rochemethods on Roche clinical chemis-try analysers as specified in thevalue sheets.</td></tr><tr><td colspan="1" rowspan="1">Format</td><td colspan="1" rowspan="1">Lyophilized calibrator based onhuman serum with constituentsadded as required to obtain desiredcomponents levels</td><td colspan="1" rowspan="1">Lyophilized calibrator based onhuman serum with constituentsadded as required to obtain desiredcomponents levels</td></tr><tr><td colspan="1" rowspan="1">Level</td><td colspan="1" rowspan="1">Single level</td><td colspan="1" rowspan="1">Single level</td></tr><tr><td colspan="1" rowspan="1">Handling</td><td colspan="1" rowspan="1">Carefully open the vial, avoiding theloss of lyophilizate, and pipette inexactly 3 mL of distilled/deionizedwater. Carefully close the vial anddissolve the contents completely byoccasional gentle swirling within 30minutes avoiding the formation offoam.</td><td colspan="1" rowspan="1">Carefully open one bottle, avoidingthe loss of lyophilizate, and pipettein exactly 3 mL of distilled/deionizedwater. Carefully close the bottle anddissolve the contents completely byoccasional gentle swirling within 30minutes. Avoid the formation offoam.</td></tr><tr><td colspan="1" rowspan="1">Traceability</td><td colspan="1" rowspan="1">Traceability information is given inthe value sheet included in the box.</td><td colspan="1" rowspan="1">Traceability of the target value isgiven in the respective instructionfor use of the system reagents.</td></tr><tr><td colspan="1" rowspan="1">Stability</td><td colspan="1" rowspan="1">Lyophilized:To store at 2-8°C and protectedfrom light until the expiry dateAfter reconstitution, the stabilitiesare :Between 15-25 °C :8 hours</td><td colspan="1" rowspan="1">Lyophilized:Stable at 2-8°C up to expirationdate.After reconstitution, the stabilities*are :- 8 hours at 15-25 °C.</td></tr><tr><td></td><td>Between 2-8 °C: 2 days Between (-25)-(-15) °C : 4 weeks (when frozen once) . Exceptions : - Stability of direct bilirubin (when stored protected from light): Between 15-25 °C: 3 hours Between 2-8 °C: 8 hours Between (-25)-(-15) °C: 2 weeks (when frozen once) - Stability of total bilirubin (when stored protected from light): Between 15-25 °C: 6 hours Between 15-25 °C: Between 2-8 °C: 1 day Between (-25)-(-15) °C:2 weeks (when frozen once) Between 2-8 °C: Between (-25)-(-15) °C: 2 weeks (when frozen once)</td><td>- 2 days at 2-8 °C. - 4 weeks at Between (-25)-(-15) °C (when frozen once) Exception for bilirubin total &amp; direct - Stability of direct bilirubin (when stored protected from light): Between 15-25 °C: 3 hours Between 2-8 C 8 hours Between (-25)-(-15) °C:2 weeks (when frozen once) - Stability of total bilirubin (when stored protected from light):</td></tr></table>

# Device names

# CONTROLS:

# Trade/proprietary Name: ELITech Clinical Systems ELITROL I and ELITROL II

Common or Usual Name:   
Device Class   
Classification name   
Product code

I Name: Multi-analyte controls - all kinds, "ELITROL I"- "ELITROL II" Class I Quality control material (assayed and unassayed). (21 CFR 862.1660) JJY- Multi-analyte controls — all kinds

Roche Diagnostics Precinorm U (K041227) Roche Diagnostics Precipath U (K041227)

# Device description

ELITech Clinical Systems ELITROL I and ELITROL l1 are two level quality control products consisting of lyophilized human serum containing constituents at desired levels.   
Elitrol I and Elitrol Il are prepared exclusively from the blood of donors tested individually and found to be negative for HbsAg and to antibodies to HCV and HIV according to FDA-approved methods or methods in compliance with the European Directive 98/79/EC, Annex II, List A.

# Intended Use

ELITech Clinical Systems ELITROL I and ELITROL II are multi-parametric control sera for in vitro diagnostic use in quality control of quantitative ELITech Clinical Systems methods on ELITech Clinical Systems Selectra Analyzers.

# Comparison to Predicate device

<table><tr><td></td><td>ELITech Clinical Systems Device (ELITROL I /ELITROL I)</td><td>Predicate Device (Roche Precinorm U / Precipath U K041227)</td></tr><tr><td>Intended use</td><td>ELITech Clinical Systems ELITROL and ELITROL&#x27; II are multi- parametric control sera for in vitro diagnostic use in quality control of quantitative ELITech Clinical Sys- tems methods on ELITech Clinical Systems Selectra Analyzers.</td><td>For in vitro diagnostic use in quality control by monitoring accuracy and precision for the quantitative .meth- ods as specified in the value sheet</td></tr><tr><td>Format</td><td>Lyophilized human sera with con- stituents added as required to ob- tain desired components levels</td><td>Lyophilized human sera with con- stituents added as required to ob- tain desired components levels</td></tr><tr><td>Levels Handling</td><td>Two levels Carefully open the vial, avoiding the</td><td>Two levels Carefully open the bottle, avoiding the loss of lyophilizate, and pipette</td></tr><tr><td></td><td>loss of lyophilizate, and pipette in exactly 5 mL of distilled/deionized water. Carefuily close the vial and dissolve the contents completely by occasional gentle swirling within 30 minutes avoiding the formation of foam. Lyophilized:</td><td>in exactly 5 mL of distilled/deionized water. Carefully close the bottle and dissolve the contents completely by occasional gentle swirling within 30 minutes. Avoid the formation of foam.</td></tr><tr><td rowspan="5">Stability</td><td>To store at 2-8°C and protected from light until the expiry date After reconstitution, the stabilities are : Between 15-25  : 12 hours</td><td>Lyophilized: Stable at 2-8°C up to expiration date. After reconstitution, the stabilities* are : - 12 hours at 15-25 °C.</td></tr><tr><td>Between 2-8 °C : 5 days Between (-25)-(-15) C : 4 weeks (when frozen once) Exceptions:</td><td>- 5 days at 2-8 °C. - 4 weeks at (-25)-(-15) °C (when frozen once) *Exception for bilirubin total &amp; direct</td></tr><tr><td>- Stability of direct bilirubin (when stored protected from light): Between 15-25 °C: 4 hours Between 2-8 °C: 8 hours Between (-25)-(-15) °C:2 weeks (when frozen once)</td><td>as noted in package insert: - Stability of direct bilirubin (when stored protected from light): Between 15-25 °C: 4 hours Between 2-8 °C: 8 hours</td></tr><tr><td>- Stability of total bilirubin (when stored protected from light): Between 15-25 C: 8 hours Between 2-8 °C:</td><td>Between (-25)-(-15) °C: 2 weeks (when frozen once) - Stability of total bilirubin (when</td></tr><tr><td>1 day Between (-25)-(-15) °C: 2 weeks (when frozen once)</td><td>stored protected from light): Between 15-25 °C: 8 hours Between 2-8 °C: 24 hours Between (-25)-(-15) °C:2 weeks (when frozen once)</td></tr></table>

# Conclusion

The performance data and other information demonstrate that the safety and effectiveness of these devices versus the predicate devices are not compromised, and that it met all acceptance criteria, demonstrating that the device is substantially equivalent to its respective predicate device.

# Device name

# CALIBRATOR :

Trade/proprietary Name: ELITech Clinical Systems ELICAL 2

Common or Usual Name:   
Device Class   
Classification name   
Product code

Calibrator, multi-analyte mixture, "ELICAL 2" Class II Calibrator (21 CFR 862.1150) JIX- Calibrator, multi-analyte mixture

# Predicate device

# Roche Diagnostics Calibrator for Automated Systems (C.f.a.s) (K033501)

# Device description

ELITech Clinical Systems ELICAL 2 is a lyophilized calibrator based on human serum containing constituents to ensure optimal calibration. ELICAL 2 is prepared exclusively from the blood of donors tested individually and found to be negative for HbsAg and to antibodies to HCV and HIV according to FDA-approved methods or methods in compliance with the European Directive 98/79/EC, Annex II, List A.

# Intended Use

ELITech Clinical Systems ELICAL 2 is a multi-parametric calibrator for in vitro diagnostic use in the calibration of quantitative ELITech Clinical Systems methods on ELTech Clinical Systems Selectra Analyzers.

# Comparison to Predicate device

Page 5.7 of 5.10 pages   

<table><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">ELITech Clinical Systems DevicePR4E(ELICAL 2)    CAJN</td><td colspan="1" rowspan="1">Predicate device       5#;(Roche Calibrator f.a.s. K033501)</td></tr><tr><td colspan="1" rowspan="1">Intended use</td><td colspan="1" rowspan="1">ELITech Clinical Systems ELICAL2 is a multi-parametric calibratorfor in vitro diagnostic use in thecalibration of quantitative ELITechClinical Systems methods onELITech Clinical SystemsSelectra Analyzers.</td><td colspan="1" rowspan="1">For in vitro diagnostic use in thecalibration of quantitative Rochemethods on Roche clinicalchemistry analysers as specified inthe value sheets.</td></tr><tr><td colspan="1" rowspan="1">Format</td><td colspan="1" rowspan="1">Lyophilized calibrator based onhuman serum with constituentsadded as required to obtain desiredcomponents levels</td><td colspan="1" rowspan="1">Lyophilized calibrator based onhuman serum with constituentsadded as required to obtain desiredcomponents levels</td></tr><tr><td colspan="1" rowspan="1">Level</td><td colspan="1" rowspan="1">Single level</td><td colspan="1" rowspan="1">Single level</td></tr><tr><td colspan="1" rowspan="1">Handling</td><td colspan="1" rowspan="1">Carefully open the vial, avoiding theloss of lyophilizate, and pipette inexactly 3 mL of distilled/deionizedwater. Carefully close the vial anddissolve the contents completely byoccasional gentle swirling within 30minutes avoiding the formation offoam.</td><td colspan="1" rowspan="1">Carefully open one bottle, avoidingthe loss of lyophilizate, and pipettein exactly 3 mL of distilled/deionizedwater. Carefully close the bottle anddissolve the contents completely byoccasional gentle swirling within 30minutes. Avoid the formation offoam.</td></tr><tr><td colspan="1" rowspan="1">Traceability</td><td colspan="1" rowspan="1">Traceability information is given inthe value sheet included in the box.</td><td colspan="1" rowspan="1">Traceability of the target value isgiven in the respective instructionfor use of the system reagents.</td></tr><tr><td>Stability</td><td>Lyophilized: To store at 2-8°C and protected from light until the expiry date</td><td>Lyophilized: Stable at 2-8°C up to expiration date.</td></tr><tr><td>are :</td><td>After reconstitution, the stabilities</td><td>After reconstitution, the stabilities* are :</td></tr><tr><td></td><td>Between 15-25 C : 8 hours</td><td>- 8 hours at 15-25 C.</td></tr><tr><td></td><td>Between 2-8 C : 2 days Between (-25) (-15) C : 4 weeks (when frozen once) Exceptions :</td><td>- 2 days at 2-8 °C. - 4 weeks at Between (-25)-(-15) °C (when frozen once)</td></tr><tr><td></td><td>- Stability of direct bilirubin (when stored protected from light):</td><td>Exception for bilirubin total &amp; direct - Stability of direct bilirubin (when stored protected from light):</td></tr><tr><td></td><td>Between 15-25 C: 3 hours Between 2-8 °C: 8 hours</td><td>Between 15-25 °C: 3 hours</td></tr><tr><td></td><td>Between (-25)(-15) °C: 2 weeks (when frozen once)</td><td>Between 2-8 8 hours Between (-25)-(-15) °C: 2 weeks</td></tr><tr><td></td><td>- Stability of total bilirubin (when stored protected from light):</td><td>(when frozen once) - Stability of total bilirubin (when</td></tr><tr><td></td><td>Between 15-25 °C: 6 hours</td><td>stored protected from light):</td></tr><tr><td></td><td>Between 2-8 °C: 1 day Between (-25)-(-15) °C: 2 weeks</td><td>Between 15-25 °C: 6 hours</td></tr><tr><td></td><td>(when frozen once)</td><td>Between 2-8 °C: 1 day Between (-25)-(-15) °C: 2 weeks (when frozen once)</td></tr></table>

# Device names

# CONTROLS:

Trade/proprietary Name: ELITech Clinical Systems ELITROL I and ELITROL II

Common or Usual Name: Multi-analyte controls - all kinds, "ELITROL I". "ELITROL II"   
Device Class Class I   
Classification name Quality control material (assayed and unassayed). (21 CFR 862.1660)   
Product code JJY- Multi-analyte controls - all kinds

# Predicate device

Roche Diagnostics Precinorm U (K041227) Roche Diagnostics Precipath U (K041227)

# Device description

ELITech Clinical Systems ELITROL I and ELITROL I are two level quality control products consisting of lyophilized human serum containing   
constituents at desired levels.   
El  and Elitrol  are prepare exlusively rom the blood  donors tested individually and found to be negative for HbsAg and to antibodies to HCV and HIV according to FDA-approved methods or methods in compliance with the European Directive 98/79/EC, Annex II List A.

# Intended Use

ELITech Clinical Systems ELITROL I and ELITROL II are multi-parametric control sera for in vitro diagnostic use in quality control of quantitative ELITech Clinical Systems methods on ELITech Clinical Systems Selectra Analyzers.

# Comparison to Predicate device

Page 5.9 of 5.10 pages   

<table><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">ELITech Clinical Systems Device(ELITROLI/ELITROLII)  94:</td><td colspan="1" rowspan="1">Predicate Device(Roche Precinorm U/ Precipath U)K041227    1E</td></tr><tr><td colspan="1" rowspan="1">Intended use</td><td colspan="1" rowspan="1">ELITech Clinical Systems ELITROLI and ELITROL II are multi-parametric control sera for in vitrodiagnostic use in quality control ofquantitative ELITech ClinicalSystems methods on ELITechClinical Systems SelectraAnalyzers.</td><td colspan="1" rowspan="1">For in vitro diagnostic use in qualitycontrol by monitoring accuracy andprecision for the quantitativemethods as specified in the valuesheet</td></tr><tr><td colspan="1" rowspan="1">Format</td><td colspan="1" rowspan="1">Lyophilized human sera withconstituents added as required toobtain desired components levels</td><td colspan="1" rowspan="1">Lyophilized human sera withconstituents added as required toobtain desired components levels</td></tr><tr><td colspan="1" rowspan="1">Leveis</td><td colspan="1" rowspan="1">Two levels</td><td colspan="1" rowspan="1">Two levels</td></tr><tr><td colspan="1" rowspan="1">Handling</td><td colspan="1" rowspan="1">Carefully open the vial, avoiding theloss of lyophilizate, and pipette inexactly 5 mL of distilled/deionizedwater. Carefully close the vial anddissolve the contents completely byoccasional gentle swirling within 30minutes avoiding the formation offoam.</td><td colspan="1" rowspan="1">Carefully open the bottle, avoidingthe loss of lyophilizate, and pipettein exactly 5 mL of distilled/deionizedwater. Carefully close the bottle anddissolve the contents completely byoccasional gentle swirling within 30minutes. Avoid the formation offoam.</td></tr><tr><td colspan="1" rowspan="1">Stability</td><td colspan="1" rowspan="1">Lyophilized:To store at 2-8°C and protectedfrom light until the expiry date</td><td colspan="1" rowspan="1">Lyophilized:Stable at 2-8°C up to expirationdate.</td></tr><tr><td colspan="1" rowspan="1">M</td><td colspan="1" rowspan="1">ELITech Clinical Systems Device(ELITROL WELITROLII).</td><td colspan="1" rowspan="1">Predicate Device(Roche Precinorm U/ Precipath U</td></tr><tr><td colspan="1" rowspan="2"></td><td colspan="1" rowspan="2">After reconstitution, the stabilitiesare :Between 15-25 °C :    12 hoursBetween 2-8 °C :      5 daysBetween (-25) (-15) C : 4 weeks(when frozen once)Exceptions:- Stability of direct bilirubin (whenstored protected from light):Between 15-25 °C:    4 hoursBetween 2-8 °C:       8 hoursBetween (-25)-(-15) °C: 2 weeks(when frozen once)- Stability of total bilirubin (whenstored protected from light):Between 15-25 C:    8 hoursBetween 2-8 C:       1 dayBetween (-25)-(-15) °C: 2 weeks(when frozen once)</td><td colspan="1" rowspan="1">After reconstitution, the stabilities*are :- 12 hours at 15-25 C.- 5 days at 2-8 °C.- 4 weeks at (-25)-(-15) °C (whenfrozen once)*Exception for bilirubin total &amp; direct</td></tr><tr><td colspan="1" rowspan="1">as noted in package insert:- Stability of direct bilirubin (whenstored protected from light):Between 15-25 C:    4 hoursBetween 2-8 °C:       8 hoursBetween (-25) (-15) C: 2 weeks(when frozen once)- Stability of total bilirubin (whenstored protected from light):Between 15-25 C:    8 hoursBetween 2-8 C:       24 hoursBetween (-25)-(-15) °C: 2 weeks(when frozen once)</td></tr></table>

# Conclusion

The performance data and other information demonstrate that the safety and effectiveness of these devices versus the predicate devices are not compromised, and that it met all acceptance criteria, demonstrating that the device is substantially equivalent to its respective predicate device.

SEPPIM S.A.S.   
Elitech Group Epoch Biosciences   
c/o Ms. Debra Hutson   
Director, Quality Assurance/Regulatory Affairs 21720 23rd Drive, S.E., Suite 150   
Bothell, Washington 98021

Re: k110830 Trade Name: ELITech Clinical Systems Albumin, ELITech Clinical Systems Calcium Arsenazo, ELITech Clinical Systems Elical 2, ELITech Clinical Systems Elitrol I and II Regulation Number: 21 CFR $\ S 8 6 2 . 1 0 3 5$ EPY Regulation Name: Albumin Test System Regulatory Class: Class II Product Codes: CIX, CJY, JIX, JJY Dated: May 18, 2011 Received: May 19, 2011

Dear Ms. Hutson:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.

You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); and good

Page 2 -

If you desire specific advice for your device on our labeling regulation (21 CFR Pars 801 and 809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796- 5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office .--of Surveillance and-Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address   
http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

GC.

:

Courthey Harper, Ph.D.   
Director   
Division of Chemistry and Toxicology   
Office of In Vitro Diagnostic Device   
Evaluation and Safety   
Center for Devices and Radiological Health

# Indications for Use Form

510(k) Number (if known): K110830 Device Name: _ELITech Clinical Systems CALCIUM ARSENAZO

Indications for Use:

ELITech Clinical Systems CALCIUM ARSENAZO is intended for the quantitative in vitro diagnostic determination of total calcium in human serum and plasma on ELITech Clinical Systems Selectra analyzers.

It is not intended for use in Point of Care settings.

Calcium measurements are used in the diagnosis and treatment of parathyroid disease, a variety of bone diseases, chronic renal disease and tetany (intermittent muscular contractions or spasms).

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of In Vito Diagnostic Devices (OIVD)

![](images/98861121251ad82ace3b8c8f02afff22c84d5ecce5c639b50d1e7f1457755037.jpg)

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety

510(k)k110830

# Indications for Use Form

510(k) Number (if known): K110830 Device Name: ELITech Clinical Systems ALBUMIN

Indications for Use:

ELITech Clinical Systems ALBUMIN is intended for the quantitative in vitro diagnostic determination of albumin in human serum and plasma on ELITech Clinical Systems Selectra analyzers.

It is not intended for use in Point of Care settings.

Albumin measurements are used in the diagnosis and treatment of numerous diseases involving primarily the liver or kidneys.

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

![](images/bc337d736afa85738245471748a0132299add125e83e23bd5a3a0596880211a1.jpg)

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety

510(k) 1C110830

# Indications for Use Form

510(k) Number (ifknown): K110830   
Device Name: ELITech Clinical Systems ELICAL 2

Indications for Use:

ELITech Clinical Systems ELICAL 2 is a multi-parametric calibrator for in vitro diagnostic use in the calibration of quantitative ELITech Clinical Systems methods on ELITech Clinical Systems Selectra analyzers.

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

![](images/ad543a77b4aee3c179cf76b324f0a20eef84a48079fa7d8447eed053660b43d5.jpg)

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety

510(k12110830

# Indications for Use Form

510(k) Number (i known): K1/0830 Device Name: ELITech Clinical Systems ELITROL I & ELITROL II

Indications for Use:

ELITech Clinical Systems ELITROL I & ELITROL II are multi-parametric control sera for in vitro diagnostic use in quality control of quantitative ELiTech Clinical Systems methods on ELITech Clinical Systems Selectra analyzers.

(cription Ue AND/OR (ver-The-Counter Uuse)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

![](images/f84b853c33bce889ada7a1830e7a04d807156024041fc2182f276f9eedd83d87.jpg)

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety

510(k) K 110830